pharmaceutical companies manufacturing glp-1 receptor agonist medications agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Frontiers | GLP−1 receptor agonists

GLP-1 receptor agonists lower HbA1c by 11.5% but this may be dependent of the type of GLP-1 receptor agonist prescribed, the dosage, baseline HbA1c levels and glucose-lowering co-medication [24]

Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health

Epub 2020 Mar 16

Real Patient Success Stories These are actual patient experiences from Wittmer Rejuvenation Clinic: Case Study 1: Male, Age 43, Starting Weight 225 lbs Protocol: 225mcg CJC-1295/Ipamorelin daily for 24 weeks Nutrition: 2200 calories, 200g protein, moderate carb cycling Training: 4x per week resistance + 2x per week HIIT Results: Weight: 225 195 lbs (30 lbs lost) Estimated fat loss: 35-38 lbs Estimated muscle gain: 5-8 lbs Waist: 38" 32" (6 inches lost) Body fat: ~28% ~15% "I've tried every diet out there